Moc-L-Tert-Leucine CAS 162537-11-3 Purity ≥99.0% (HPLC) Atazanavir Intermediate Factory

Short Description:

Chemical Name: Moc-L-Tert-Leucine

CAS: 162537-11-3

Appearance: White to Off-White Crystals

Purity: ≥99.0% (HPLC)

Intermediate of Atazanavir HIV-1 Protease Inhibitor

High Quality, Commercial Production

Inquiry: alvin@ruifuchem.com

Send email to us

Product Detail

Product Tags

Description:

Manufacturer Supply with High Purity and Stable Quality
Chemical Name: Moc-L-Tert-Leucine
CAS: 162537-11-3
Intermediate of Atazanavir HIV-1 Protease Inhibitor
High Quality, Commercial Production

Chemical Properties:

Chemical Name	Moc-L-Tert-Leucine
Synonyms	Methoxycarbonyl-L-tert-Leucine; N-(Methoxycarbonyl)-tert-Leucine; Atazanavir Related Compound A
CAS Number	162537-11-3
CAT Number	RF-PI289
Stock Status	In Stock, Production Scale Up to Tons
Molecular Formula	C8H15NO4
Molecular Weight	189.21
Melting Point	109℃
Density	1.126 g/cm3
Boiling Point	320.9℃ at 760 mmHg
Solubility	Soluble in Ethyl Acetate and Methanol
Shipping Condition	Shipped Under Ambient Temperature
Brand	Ruifu Chemical

Specifications:

Item	Specifications
Appearance	White to Off-White Crystals
Identification Methods	HPLC
Purity/Analysis Method	≥99.0% (HPLC)
Moc-L-Tle-Tle-OH	≤0.30%
L-Moc-Dimer	≤0.30%
L-Tle-OH	≤0.10%
Methoxycarbonyl-L-Valine	≤0.10%
N-Acetyl-L-tert-Leucine	≤0.05%
Individual Unkown Impurity	≤0.30%
Total Impurities	≤1.0%
Enantiomer Content	≤0.10% (By Chiral HPLC)
Water Content	≤0.50% (By K.F)
Loss on Drying	≤0.50%
Residue on Ignition	≤0.20%
Heavy Metals	≤10ppm
Usage	Amino Acid; Intermediate of Atazanavir (CAS 198904-31-3)

Package & Storage:

Package: Bottle, Aluminium foil bag, 25kg/Drum, or according to customer's requirement.

Storage Condition: Store in sealed containers at cool and dry place; Protect from light, moisture.

Advantages:

FAQ:

Application:

Shanghai Ruifu Chemical Co., Ltd. is the leading manufacturer and supplier of Moc-L-Tert-Leucine (CAS 162537-11-3) with high quality. Moc-L-Tert-Leucine is a kind of amino acid deriviative. It is a very useful intermediate for efficient synthesis of the HIV protease inhibitor Atazanavir (CAS 198904-31-3) as well as Atazanavir sulfate (CAS 229975-97-7).

Atazanavir is an antiretroviral agent that has been approvedby the FDA for use in combination with other anti-RTagents for the treatment of HIV infections. The drug is always used in combination with RT inhibitors. Atazanavir is an inhibitor of HIV-1 protease (EC50=2.6 nM). In isolated cells, it has additive to moderately synergistic antiviral effects when combined with other antiretroviral drugs. As a result, it is commonly used in vivo in combination therapy for HIV-1 infection.